Evidence map›Paper›PMID 22966206›Full record

ArticleMolecular and cellular biology2012

Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Matthew R Pawlus, Liyi Wang, Katie Ware, Cheng-Jun Hu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cellular and molecular life sciences : CMLS · 2025
    Review
  7. Open veterinary journal · 2024
    Article
  8. Article
  9. Fount, fate, features, and function of renal erythropoietin-producing cells.Pflugers Archiv : European journal of physiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Matthew R PawlusMolecular Biology Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Liyi Wang
Katie Ware
Cheng-Jun Hu
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Cancer Center · USUniversity of Colorado Denver · US

Funding

Predoctoral Training Program in Molecular BiologyT32GM008730 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PREKERIS, RYTIS, SCLAFANI, ROBERT A · 1999 to 2019
$3.3M
Regulation of Transcriptional Activity of Hypoxia Inducible Factor 2R01CA134687 · NCI · UNIVERSITY OF COLORADO DENVER · PI HU, CHENG-JUN · 2008 to 2012
$1.5M
NCI NIH HHS R01 CA134687NCI NIH HHS R01CA134687NIGMS NIH HHS NIHT32-GM08730NIGMS NIH HHS T32 GM008730
6 · The paper itself

Abstract

While the functions of hypoxia-inducible factor 1α (HIF1α)/aryl hydrocarbon receptor nuclear translocator (ARNT) and HIF2α/ARNT (HIF2) proteins in activating hypoxia-inducible genes are well established, the role of other transcription factors in the hypoxic transcriptional response is less clear. We report here for the first time that the basic helix-loop-helix-leucine-zip transcription factor upstream stimulatory factor 2 (USF2) is required for the hypoxic transcriptional response, specifically, for hypoxic activation of HIF2 target genes. We show that inhibiting USF2 activity greatly reduces hypoxic induction of HIF2 target genes in cell lines that have USF2 activity, while inducing USF2 activity in cells lacking USF2 activity restores hypoxic induction of HIF2 target genes. Mechanistically, USF2 activates HIF2 target genes by binding to HIF2 target gene promoters, interacting with HIF2α protein, and recruiting coactivators CBP and p300 to form enhanceosome complexes that contain HIF2α, USF2, CBP, p300, and RNA polymerase II on HIF2 target gene promoters. Functionally, the effect of USF2 knockdown on proliferation, motility, and clonogenic survival of HIF2-dependent tumor cells in vitro is phenocopied by HIF2α knockdown, indicating that USF2 works with HIF2 to activate HIF2 target genes and to drive HIF2-depedent tumorigenesis.

Indexed as

Transcriptional ActivationAnimalsBasic Helix-Loop-Helix ProteinsCell Line, TumorCell ProliferationCell SurvivalCell Transformation, NeoplasticCREB-Binding ProteinEndothelial PAS Domain-Containing Protein 1HumansHypoxiaMiceMice, Knockoutp300-CBP-Associated Factorp300-CBP Transcription FactorsPlasmidsBasic Helix-Loop-Helix ProteinsCREB-Binding ProteinCREBBP protein, humanEndothelial PAS Domain-Containing Protein 1p300-CBP-Associated Factorp300-CBP Transcription FactorsRNA Polymerase IIRNA, Small InterferingUpstream Stimulatory FactorsUSF2 protein, human

Identifiers

PMID22966206
PMCPMC3486188
OpenAlexW2111018768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.